Source: Eur Respir J, 53 (2) 1800893; 10.1183/13993003.00893-2018
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Alberto García-Ortega, Eva Mañas, Raquel López-Reyes, María José Selma, Aldara García-Sánchez, Grace Oscullo, David Jiménez, Miguel Ángel Martínez-García. Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications. Eur Respir J, 53 (2) 1800893; 10.1183/13993003.00893-2018

Member's Comments

No comment yet.

Related content which might interest you: Obstructive sleep apnoea and risk of recurrent venous thromboembolism Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016 Increased arterial stiffness in patients with obstructive sleep apnea: clinical implication Source: Sleep and Breathing Conference 2021 Year: 2021 Obstructive sleep apnea is a great threat in patients' with acute pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Obstructive sleep apnea and prognosis in acute pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Obstructive sleep apnea and specific cardiovascular outcomes Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013 Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis Source: Eur Respir J, 49 (6) 1601934; 10.1183/13993003.01934-2016 Year: 2017 Obstructive sleep apnoea and pulmonary involvement in patients with scleroderma Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Guidelines 2013 Year: 2013 Obstructive sleep apnea can cause pulmonary hypertension in the absence of lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Pathophysiology of obstructive sleep apnoea: from clinical closing pressure to ventilatory Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more Year: 2019 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Sleep apnoea and hypoventilation syndromes: pathophysiological consequences Source: International Congress 2017 – PG13 Sleep-disordered breathing: diagnosis and therapy Year: 2017 Obstructive sleep apnea in patients with typical atrial flutter: Clinical, prognostic and therapeutic implications Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Obstructive sleep apnoea and asthma: a particular association? Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003 Obstructive sleep apnea syndrome as an arterial hypertension risk factor – clinical study Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli? Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II Year: 2011